Stoke Therapeutics, Inc. (STOK)
35.60
-0.63
(-1.74%)
USD |
NASDAQ |
Feb 24, 15:58
Stoke Therapeutics Market Cap : 2.033B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 28.64B |
| Insmed, Inc. | 33.84B |
| Pfizer Inc. | 154.31B |
| Mirum Pharmaceuticals, Inc. | 5.516B |
| Moderna, Inc. | 19.74B |
Market Cap Related Metrics
| PE Ratio | 53.95 |
| PS Ratio | 10.10 |
| Price to Book Value | 6.600 |
| Price to Free Cash Flow | 39.67 |
| Price | 35.60 |
| Earnings Yield | 1.85% |
| Operating PE Ratio | 76.38 |
| Normalized PE Ratio | 53.95 |